Centessa Pharmaceuticals Plc ADR
(CNTA)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -381,900 | -321,126 | -280,971 | -239,520 | -10,663 |
| Depreciation Amortization | 34 | 22 | 9 | 2 | 0 |
| Accounts payable and accrued liabilities | 3,799 | 5,171 | 1,801 | 6,190 | N/A |
| Other Working Capital | -5,379 | -486 | -3,325 | 3,649 | -546 |
| Other Operating Activity | 247,288 | 236,688 | 235,925 | 216,995 | 579 |
| Operating Cash Flow | $-136,158 | $-79,731 | $-46,561 | $-12,684 | $-10,630 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -186 | -122 | -74 | -37 | 0 |
| Net Acquisitions | 63,442 | 68,038 | 68,038 | 68,038 | 0 |
| Purchase Sale Intangibles | N/A | -4,596 | -4,596 | -4,484 | N/A |
| Other Investing Activity | 0 | -4,596 | -4,596 | -4,484 | 0 |
| Investing Cash Flow | $63,256 | $63,320 | $63,368 | $63,517 | $0 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 73,930 | N/A | N/A | N/A | N/A |
| Common Stock Issued | 344,915 | 292 | 346,125 | 241,889 | N/A |
| Common Stock Repurchased | N/A | 344,136 | -12 | N/A | N/A |
| Other Financing Activity | 241,302 | 241,290 | 241,597 | 0 | 1,362 |
| Financing Cash Flow | $660,147 | $585,718 | $587,710 | $241,889 | $1,362 |
| Exchange Rate Effect | 1,902 | 3,573 | 3,308 | -44 | -75 |
| Beginning Cash Position | 12,193 | 12,193 | 12,192 | 12,192 | 16,570 |
| End Cash Position | 601,340 | 585,073 | 620,017 | 304,870 | 7,227 |
| Net Cash Flow | $589,147 | $572,880 | $607,825 | $292,678 | $-9,343 |
| Free Cash Flow | |||||
| Operating Cash Flow | -136,158 | -79,731 | -46,561 | -12,684 | -10,630 |
| Capital Expenditure | -186 | -122 | -74 | -37 | N/A |
| Free Cash Flow | -136,344 | -79,853 | -46,635 | -12,721 | -10,630 |